STOK
Stoke Therapeutics, Inc.
Latest Form 4:Sale$153KbyTicho Barry (CHIEF MEDICAL OFFICER) · filed Aug 19, 2026
Stoke Therapeutics, Inc. (STOK) has 43 SEC Form 4 filings (117 transaction rows) in the rolling window, disclosed by 8 distinct insiders. Most recent filing: Aug 19, 2026.
The most active filer is CHIEF MEDICAL OFFICER Ticho Barry with 16 filings. Insiders have net sold $4.4M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Ian F. Smith
- Employees:170
- HQ:Bedford, MA, US
- IPO:2019-06-19
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$12.7M
reported sales (SEC code S)
Unique Insiders
8
in the rolling window
Market Cap
$2.0B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| CHIEF MEDICAL OFFICER | Sale | 4,767 | $153K | Aug 19 | SEC ↗ | |
| Director | Sale | 12,567 | $403K | Aug 19 | SEC ↗ | |
| GENERAL COUNSEL & CORP SEC | Sale | 2,861 | $92K | Aug 19 | SEC ↗ | |
| CHIEF MEDICAL OFFICER | Sale | 7,176 | $208K | Aug 5 | SEC ↗ | |
| CHIEF MEDICAL OFFICER | Sale | 7,228 | $236K | Jul 6 | SEC ↗ | |
| GENERAL COUNSEL & CORP SEC | Sale | 1,457 | $44K | Jun 18 | SEC ↗ | |
| CHIEF MEDICAL OFFICER | Sale | 1,795 | $55K | Jun 3 | SEC ↗ | |
| CHIEF MEDICAL OFFICER | Sale | 2,243 | $74K | May 5 | SEC ↗ | |
| CHIEF MEDICAL OFFICER | Sale | 1,838 | $60K | Apr 3 | SEC ↗ | |
| GENERAL COUNSEL & CORP SEC | Sale | 9,293 | $313K | Mar 24 | SEC ↗ | |
Ticho BarryFirst in 3 months | CHIEF MEDICAL OFFICER | Sale | 6,164 | $203K | Mar 19 | SEC ↗ |
Ticho BarryFirst in 3 months | CHIEF MEDICAL OFFICER | Sale | 6,686 | $210K | Mar 19 | SEC ↗ |
Ticho BarryFirst in 3 months | CHIEF MEDICAL OFFICER | Sale | 1,461 | $44K | Mar 19 | SEC ↗ |
Leggett ThomasFirst filing | Chief Financial Officer | Sale | 2,196 | $72K | Mar 19 | SEC ↗ |
Leggett ThomasFirst filing | Chief Financial Officer | Sale | 2,382 | $75K | Mar 19 | SEC ↗ |
Hoitt JasonFirst filing | Chief Patient Officer | Sale | 1,781 | $59K | Mar 19 | SEC ↗ |
Hoitt JasonFirst filing | Chief Patient Officer | Sale | 1,931 | $61K | Mar 19 | SEC ↗ |
Allan JonathanFirst in 3 months | GENERAL COUNSEL & CORP SEC | Sale | 4,267 | $141K | Mar 19 | SEC ↗ |
Allan JonathanFirst in 3 months | GENERAL COUNSEL & CORP SEC | Sale | 4,628 | $145K | Mar 19 | SEC ↗ |
| Director | Sale | 605 | $22K | Mar 17 | SEC ↗ | |
TZIANABOS ARTHURFirst filing | Interim Executive Chair | Sale | 4,355 | $174K | Mar 12 | SEC ↗ |
| Director | Sale | 33,243 | $1.3M | Mar 12 | SEC ↗ | |
Krainer Adrian R.First in 3 months | Director | Sale | 7,229 | $287K | Mar 4 | SEC ↗ |
| Director | Sale | 13,430 | $433K | Dec 10 | SEC ↗ | |
| GENERAL COUNSEL & CORP SEC | Sale | 3,978 | $128K | Dec 10 | SEC ↗ | |
| Insider | Sale | 6,453 | $199K | Dec 5 | SEC ↗ | |
| Insider | Sale | 8,548 | $268K | Dec 5 | SEC ↗ | |
| CHIEF MEDICAL OFFICER | Sale | 1,696 | $52K | Dec 5 | SEC ↗ | |
| CHIEF MEDICAL OFFICER | Sale | 3,662 | $115K | Dec 5 | SEC ↗ | |
| GENERAL COUNSEL & CORP SEC | Sale | 1,018 | $31K | Dec 5 | SEC ↗ | |
| GENERAL COUNSEL & CORP SEC | Sale | 8,785 | $275K | Dec 5 | SEC ↗ | |
| CHIEF MEDICAL OFFICER | Sale | 2,006 | $60K | Dec 3 | SEC ↗ | |
| CHIEF MEDICAL OFFICER | Sale | 2,014 | $62K | Dec 3 | SEC ↗ | |
| Director | Sale | 1,066 | $32K | Dec 3 | SEC ↗ | |
| Director | Sale | 1,070 | $33K | Dec 3 | SEC ↗ | |
| GENERAL COUNSEL & CORP SEC | Sale | 2,284 | $68K | Dec 3 | SEC ↗ | |
| GENERAL COUNSEL & CORP SEC | Sale | 2,292 | $70K | Dec 3 | SEC ↗ | |
| Director | Sale | 40,472 | $1.2M | Nov 26 | SEC ↗ | |
Krainer Adrian R.First filing | Director | Sale | 40,472 | $1.1M | Nov 18 | SEC ↗ |
| CHIEF MEDICAL OFFICER | Sale | 5,931 | $153K | Nov 5 | SEC ↗ | |
| Director | Sale | 25,000 | $750K | Oct 10 | SEC ↗ | |
| GENERAL COUNSEL & CORP SEC | Sale | 10,000 | $251K | Oct 7 | SEC ↗ | |
| Director | Sale | 42,461 | $1.1M | Oct 7 | SEC ↗ | |
| CHIEF MEDICAL OFFICER | Sale | 5,343 | $126K | Oct 3 | SEC ↗ | |
Allan JonathanFirst filing | GENERAL COUNSEL & CORP SEC | Sale | 850 | $17K | Sep 3 | SEC ↗ |
Allan JonathanFirst filing | GENERAL COUNSEL & CORP SEC | Sale | 14,922 | $300K | Sep 3 | SEC ↗ |
Allan JonathanFirst filing | GENERAL COUNSEL & CORP SEC | Sale | 6,345 | $127K | Sep 3 | SEC ↗ |
| Director | Sale | 1,029 | $21K | Sep 3 | SEC ↗ | |
| Director | Sale | 14,860 | $299K | Sep 3 | SEC ↗ | |
| Director | Sale | 45,996 | $926K | Sep 3 | SEC ↗ | |
Ticho BarryFirst filing | CHIEF MEDICAL OFFICER | Sale | 5,501 | $109K | Sep 3 | SEC ↗ |
Related companies
Stoke Therapeutics, Inc. is in the Healthcare sector.